SCHEMBL6326213

SCHEMBL6326213

CCc1ccc(NC(=O)c2nc(-c3ccc(SC(C)(C)C(=O)O)cc3)sc2-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 6/20 0.48
▸ PPARA Q07869 6/20 0.48
▸ PPARD Q03181 3/20 0.48
▸ MAPT P10636 4/20 0.45
▸ TP53 P04637 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ STAT3 P40763 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ OPRD1 P41143 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TLR9 Q9NR96 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SLC22A12 Q96S37 1/20 0.39
▸ DGAT1 O75907 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP9 P14780 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6335247 0.93 PPARA (0.43) PPARGPPARAPPARDMAPTTP53
SCHEMBL6326422 0.92 PPARG (0.46) PPARGPPARAPPARDMAPTTP53
SCHEMBL5727613 0.92 MAPT (0.43) PPARGPPARAPPARDMAPTTP53
SCHEMBL6328043 0.91 STAT3 (0.47) PPARGPPARAPPARDMAPTTP53
SCHEMBL6328143 0.90 PPARG (0.47) PPARGPPARAPPARDMAPTTP53
SCHEMBL6329843 0.89 MAPT (0.41) PPARGPPARAPPARDMAPTTP53
SCHEMBL6333720 0.88 PPARG (0.58) PPARGPPARAPPARDMAPTTP53
SCHEMBL6326299 0.86 XDH (0.47) PPARGPPARAPPARDMAPTL3MBTL1
SCHEMBL6325804 0.86 PPARG (0.45) PPARGPPARAPPARDMAPTTP53
SCHEMBL6326257 0.85 MAPT (0.51) MAPTTP53L3MBTL1STAT3PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION 2005-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity GPR119, EGLN3, PC PPARG 13/4885PPARA 49/4885PPARD 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback